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Contributing Factors of Unmet Needs Among Young Adult Survivors of 
Childhood Acute Lymphoblastic Leukemia with Comorbidities 
 
Abstract 
Purpose: This study aimed to: (1) describe the domains and levels of unmet needs of young adult 
survivors of childhood acute lymphoblastic leukemia (cALL) with comorbidities, and (2) to 
explore the factors associated with higher levels of unmet needs. Unmet need was considered as 
supportive care needs not met. 
Methods: The most vulnerable cALL survivors from the PETALE study cohort completed the 
Short-Form Survivor Unmet Needs Survey (SF-SUNS), the Brief Pain Inventory (BPI) and the 
15D instrument of health-related quality of life. Demographic and clinical information, including 
comorbidities, were obtained from medical records or self-reporting. The participants’ needs and 
contributing factors to their needs were evaluated using non-parametric tests. 
Results: Of the 72 participants, nine (13%) reported moderate/high levels of overall unmet needs. 
‘Worry about earning money’ (56%) and ‘Dealing with feeling tired’ (51%) were the most frequent 
unmet needs (all levels combined). The factors associated significantly with any domain of unmet 
needs were: having a comorbidity, reporting altered functional health status, high ALL risk status, 
pain, age (<26 years) and having previously received psychological support. 
Conclusion: A minority of young adult survivors of cALL with comorbidities interviewed reported 
moderate/high levels of unmet needs. However, financial concerns and emotional health and 
relationship are the two domains of greatest need. Survivors with altered health condition are most 
at risk of experiencing moderate/high levels of unmet needs. If confirmed in larger samples, 
interventions should target modifiable contributors of unmet needs such as physical health and 
comfort, fatigue, and emotional health.  
 3 
Introduction 
Childhood acute lymphoblastic leukemia (cALL) accounts for nearly one-third of childhood 
cancers, representing at least 50,000 new cases diagnosed per year worldwide.1,2 Currently, the 5-
year survival rate of these patients exceeds 90% in developed countries, where current innovative 
protocol-driven treatments are available to children.3-5 cALL is one of the most curable cancers.6 
Hence, much current research has focused on late adverse effects resulting in comorbidities, and 
on survivors’ quality of life, to prevent these complications. 
Cohort studies of cALL survivors7,8 have ascertained many late adverse effects in this population 
due to treatment toxicity and radiation exposure.7,9 Survivors frequently have cardiac 
(e.g hypertension), metabolic (e.g. diabetes, hypertension), bone (e.g. osteonecrosis), 
neurocognitive (e.g. attention, memory) and psychosocial complications (e.g. anxiety, 
depression).7-18 Survivors’ health-related quality of life can also be greatly impacted, as highlighted 
in recent systematic reviews.19,20 
These complications may be partially preventable. Indeed, there is reason to believe that nutrition 
education interventions may favorably impact cardiometabolic comorbidities.21-24 Physical activity 
can lead to general improvement in the metabolism of patients and to alleviating the adverse effects 
of treatments, and improve patients’ quality of life.25-28 Psychosocial interventions targeting 
insomnia, psychological distress and family functioning can also improve patients’ quality of 
life.29-34 However, these interventions are not systematically tailored for this population, and are 
often not based on a systematic collection of patients’ and survivors’ needs. 
To optimize the specificity of patient care and to achieve patient-centered care,35,36 patients should 
be interviewed or included in discussions for refining intervention strategies for their difficulties 
and needs.29,33,37 The assessment of unmet supportive care needs, also termed unmet needs, can 
help address the gap between survivors’ concerns and the level of assistance provided, which is 
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central to formulating a supportive care strategy.38,39 Supportive care is defined as a person-
centered approach to ‘the provision of the necessary services for those living with or affected by 
cancer to meet their informational, spiritual, emotional, social, or physical needs during diagnosis, 
treatment, or follow-up phases including issues of health promotion and prevention, survivorship, 
palliation and bereavement’.40(p.374) Unmet needs have been classified into 11 primary domains: 
physical, psychosocial/emotional, family-related, social, interpersonal/intimacy, practical, daily 
living, spiritual/existential, health system/information, patient–clinician communication, and 
cognitive.40,41 Collecting information on these survivors’ needs may be key to offering appropriate 
targeted services in clinics.38,42 Importantly, we still have very limited knowledge on the needs of 
the vulnerable population of cALL survivors.43,44 
Thus, our objectives were: (1) to describe the domains and levels of unmet needs in cALL young 
adult survivors presenting cardiac, metabolic, neurocognitive, psychological or bone 
comorbidities, and (2) to explore whether these needs were explained by health status, 
demographics or clinical history. 
 
Methods 
This analysis was part of the PETALE study, a multidisciplinary research project conducted at 
Sainte-Justine University Health Center (SJUHC, Montreal, Canada). The PETALE study aimed 
to comprehensively characterize late adverse effects and to identify the associated predictive 
biomarkers of long-term treatment-related complications in cALL survivors. The study was divided 
into two phases of recruitment, with the second phase recalling survivors who presented extreme 
phenotypes (late effects) in the first screening phase.45 For the present study, we focused on 
participants included in Phase II, who are the most vulnerable survivors of the cohort (details 
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provided below) and conducted a cross-sectional analysis of the survey performed on this subgroup 
of cALL survivors. 
 
Participants 
In Phase I, cALL survivors diagnosed between 1987 and 2010 before the age of 19 years, treated 
according to Dana-Farber Cancer Institute (DFCI)/ALL Consortium protocols 87-01 to 05-01,46 ≥5 
years from diagnosis with no recurrence, who spoke French or English and were able to complete 
self-rated questionnaires were invited to take part in the study. Patients who received a 
hematopoietic stem cell transplant or who experienced recurrence were excluded. Participants 
eligible for study Phase II were cALL young adult survivors with extreme phenotypes in at least 
one of the following domains: cardiopulmonary, metabolic, bone, psychosocial, or neurocognitive. 
We only included survivors aged ≥19 years. For example, if their measures of anxiety, depression 
or distress taken during Phase I exceeded the cut-points for clinical levels, they were invited to 
complete the Phase II investigations. Consequently, the Phase II sample is composed of the most 
vulnerable participants of the PETALE study. The full details on the study design and inclusion 
criteria for Phase II are available in Marcoux et al.45 and its Supplemental Table S1. 
 
Procedure 
Participants and their parents (if appropriate) were met between April 2014 and December 2016. 
The participants who agreed to take part in the study came to the hospital for a day of testing. The 
tests included complete biological measures, physical health examination and psychosocial 
questionnaires. The questionnaires were completed at the hospital or at home, with a mail-back 
envelope to be sent within 3 weeks. 
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The Ethics Review Committee of SJUHC approved the study protocol and it was conducted in 




Demographic and clinical variables 
Participant age, sex, ethnicity, marital status, family structure, educational background and 
professional status were self-reported. Time since diagnosis, overall clinical history including 
treatments, and information about whether they had received psychological support were collected 
from the patients’ medical files. 
 
Comorbidities 
For all Phase II participants, we also collected comorbidities clinically. The clinical director of the 
long-term follow-up clinic rated these as present or absent based on the medical files and clinical 
exams available at the assessment point using the Common Terminology Criteria for Adverse 
Events (CTCAE) version 4.03.47 No rating was available for psychological morbidity, as no 
systematic assessment of psychosocial distress was performed at the institution at the time of data 
collection. A morbidity in one domain was considered present if the domain required in-depth 
investigation or treatment. Examples of morbidities are: mineral density deficits or osteoporosis 
(bone), valvular abnormalities or ventricular arrhythmia (cardiac), attention or concentration 
deficits (neurocognitive), hyperlipidemia or type 2 diabetes (metabolic). This rating was made 





The participants’ unmet needs were assessed using the Survivor Unmet Needs Survey short form 
(SF-SUNS).48 We adapted the questionnaire into French following standard translation 
procedures.49 The 30-item questionnaire assesses four unmet need domains divided into four 
factors: (1) information (3 items; α=0.67), (2) financial concerns (8 items; α=0.84), (3) access and 
continuity of care (6 items; α=0.90), and (4) emotional health and relationship (13 items; α=0.93). 
Each domain is scored 0–4, with higher scores indicating high levels of unmet needs. Scores of 0 
were classified as no unmet needs, 0–1 as low unmet needs, 1–2 as low to moderate unmet needs, 
and 3–4 as high unmet needs.50 
 
Functional health status 
The French version of the 15D instrument of health-related quality of life (http://www.15d-
instrument.net/15d/)51 was used to measure functional health status at study Phase I 
(1.25±0.60 years prior to Phase II) across 15 domains (α=0.82): mobility, vision, hearing, 
breathing, sleeping, eating, speech, excretion, usual activities, mental function, discomfort and 
symptoms, depression, distress, vitality, and sexual activity. A single index score is obtained, 
ranging from 0 (being dead) to 1 (no problem in any dimension). 
 
Clinical pain 
The French version of the Brief Pain Inventory (BPI)52,53 was used to measure both pain severity 
(4 items; α=0.87) and pain interference (7 items; α=0.93). Pain severity was measured at its worst, 
least, average and current level. The level of functional interference caused by pain was measured 
with items assessing general activity, walking, work, mood, sleep, enjoyment of life and relations 
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The Statistical Package for the Social Sciences (SPSS, version 25) was used to conduct statistical 
analyses. First, we conducted descriptive analyses on the different measures to confirm suitability 
for parametric tests (data normality and homogeneity when applicable). Then, for Objective 1, we 
computed means, standard deviations and frequencies for each factor and item of the SF-SUNS, 
and described the most frequent needs expressed. For Objective 2, non-parametric tests were 
performed. Mann-Whitney U tests were used to explore whether unmet needs were linked to 
comorbidities, demographic and clinical characteristics. Considering possible multi-morbidity, we 
analyzed the links between unmet needs and the number of combined comorbidities with Spearman 
correlations. We also computed Spearman correlation tests to investigate the associations between 




A total of 247 eligible cALL survivors were recruited in the PETALE Phase I study. From Phase II, 
219 cALL survivors were eligible, among whom 72 young adults (≥19 years) composed the present 
study sample (flow chart in Appendix Figure 1). The participants were aged 19–42 years (mean 
age, 27±6 years), with a majority of self-reported Caucasian ethnicity (96%). The mean time since 
diagnosis was 17±6 years. Most participants had been treated with cranial radiotherapy (81%; 
maximum dose was less than or equal to 19 Gy) and approximately one-quarter had received 
support from a mental health specialist. 
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Most participants had at least one clinically significant comorbidity (n=56; 78%) according to the 
CTCAE rating: either one from among bone, metabolic or neurocognitive (n=30; 54%) or a 
combination of bone, metabolic, neurocognitive or cardiac complications (n=26; 46%). As 
summarized in Figure 1, the cardiac domain was always combined with another domain (metabolic, 
bone or neurocognitive). The most frequent morbidity domain alone was metabolic complications 
(56%). On average, the participants had 1.30±1.00 comorbidity. However, participants with 
neurocognitive complications were younger at diagnosis than participants without such 
complications (6.31±4.25 years vs. 10.67±4.92 years, U=274.00, p<.01). More specifically, 
patients who had radiotherapy and presented neurocognitive complications were younger at 
diagnosis than participants without such complications (6.60±4.37 years vs. 11.44±4.67 years, 
U=170.00, p<.01). No such statistical differences were observed for metabolic, bone or cardiac 
complications according to age at diagnosis (Appendix Table 1). Furthermore, the participants 
reported only mild levels of pain severity (1.71±1.85 on the 0–10 scale) and pain interference 
(1.17±1.78 on the 0–10 scale) as measured with the BPI, and very good overall functional health 
status (0.92±0.08 on the 0–1 scale; 15D instrument).  
Table 1 lists the complete details of the participants’ characteristics and present the differences 
between the participants included in PETALE study Phase I and Phase II. 
 
 
[INSERT TABLE 1] 
 
[INSERT FIGURE 1] 
 
 
Description of unmet needs  
 10 
Most of the participants had no unmet needs (19%) or low unmet need levels (68%) (Table 2). The 
mean levels of unmet needs were also very low (<0.60) for all domains. When present, unmet needs 
were more frequently reported in the emotional health and relationship domain. However, when 
investigating the responses for each item (Figure 2), we observed that >40% of the participants 
rated five items as an unmet need, and >20% of participants rated 15 items as an unmet need. Thus, 
some items appeared more representative of unmet needs in the present sample. Participants 
frequently reported being ‘Worried about earning money’ (item 4; 55.56%) and expressed concerns 
about ‘Paying household bills or other payments’ (item 6; 43.06%), highlighting financial 
concerns. Other needs were linked to emotions, such as ‘Dealing with feeling tired’ (item 24; 
51.39%), ‘Dealing with feeling stressed’ (item 25; 48.61%) and ‘Dealing with changes in how my 
body appears’ (item 29; 47.22%). Information, access and continuity of care were the domains with 
the fewest unmet needs for all items (reported by <20% of the participants) (Figure 2). 
 
[INSERT TABLE 2] 
 
 
[INSERT FIGURE 2] 
 
When exploring the associations among the domains of unmet needs, we found moderate–strong 
positive and significant correlations between all domains. The emotional health and relationship 
domain was strongly associated with both the financial concerns and information domains (r=0.64, 
p<.01; r=0.44, p<.01, respectively) and was moderately associated with the access and continuity 
of care domain (r=0.33, p<.01). The access and continuity of care domain was also strongly 
associated with the financial concerns and information domains (r=0.47, p<.01; r=0.43, p<.01, 
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respectively). We found a strong correlation between the financial concerns and information 
domains (r=0.40, p<.01). 
 
Contributing factors of unmet needs  
Comorbidities 
We explored the distribution of unmet needs across the domains of deteriorated health (Appendix 
Table 2). Participants with neurocognitive issues had higher levels of information (p<.05) and 
emotional health and relationship unmet needs (p<.05) than participants without neurocognitive 
late adverse effects. Participants with bone late adverse effects had higher levels of access and 
continuity of care (p<.05) unmet needs than participants without bone complications. We found no 
difference for metabolic and cardiac comorbidities. 
When examining the number of unmet needs according to the number comorbidities, we observed 
that more frequent comorbidities were accompanied by higher levels of unmet needs. This was 
particularly true for access and continuity of care (r=0.26, p<.05) (Figure 3). 
To control for multiple comorbidities, we removed participants presenting mixed profiles (n=26, 
Figure 1), and explored the level of unmet needs across the remaining three groups presenting only 
one comorbidity, i.e. metabolic (n=15), bone (n=10) or neurocognitive (n=5). The results suggested 
that participants with metabolic complications had fewer unmet needs (all domains) than 
participants with bone or neurocognitive complications, but these apparent differences did not 
reach significance in this limited sample (p>.05) (Appendix Table 3). 
 
 
[INSERT FIGURE 3] 
 
Functional health status and clinical pain 
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All domains of unmet needs were associated with functional health status and clinical pain (except 
for the financial concerns domain unrelated with clinical pain). Functional health status measured 
in Phase I was significantly and negatively associated with unmet needs (all domains). For 
example, worse functional health status was associated with more information needs and financial 
concerns (r=-0.32, p<.05; r=-0.25, p<.05, respectively). Unmet needs were also significantly and 
positively associated with pain interference (information, access and continuity of care, and 
emotional health and relationship domains) and pain severity (access and continuity of care, 
emotional health and relationship domains). Higher pain was associated with more frequent unmet 
needs. The complete results are available in Appendix Table 4. 
 
Demographic and clinical factors 
We also found that unmet needs were associated with younger age, previous psychological support 
received, and higher ALL risk status. Financial concerns were more frequent among participants 
aged <26 years and those who had received psychological support (p<.05 and p<.01, respectively). 
Participants who had received psychological support expressed more emotional health and 
relationship needs (p<.05). Participants with high ALL risk status reported access and continuity 
of care needs more frequently compared to those with standard risk (p<.05). No significant 
association was found with sex, marital status, having children, time since diagnosis and 




This study is the first to investigate the unmet supportive care needs of cALL young adult survivors 
and their contributing factors. The cALL survivors interviewed expressed few unmet needs. 
However, the most frequently expressed needs were related to the emotional health and 
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relationship, and financial domains. The factors contributing to unmet needs, depending on the 
domain, were late adverse effect, altered functional health, pain, having received psychological 
support in the past and being younger than 26 years old. Healthcare professionals could use this 
information to quickly identify and assist those in need. 
Twelve percent of our participants expressed moderate to high levels of unmet needs. This result 
is consistent with the literature, where the levels of unmet needs among survivors of hematologic 
cancer are generally low.55-58 A study conducted specifically on survivors of pediatric cancers, 
however, showed high levels of unmet needs. These needs were higher among leukemia cancer 
survivors compared to survivors of solid tumors.44 The differences found between our study and 
other studies can be linked to the country healthcare system and long-term care available. In 
Canada, universal healthcare exists. Our results are thus generalizable to countries with such 
healthcare system. However, even if our participants tended to express few unmet needs, more than 
40% of them reported specific needs related to dealing with feeling stressed or tired, dealing with 
changed body and worrying about earning money and paying household bills or other payments. 
Indeed, psychological and information needs have been identified as the most frequent needs 
among adult cancer survivors, and physical and daily living concerns are the most frequent among 
adult hematological cancer survivors.59 Thus, cALL survivors seem to have similar unmet needs 
to other cancer survivors. Yet, among the unmet need domains identified in the literature, specific 
to cancer survivors60 or not,40,41 an important one has not been explored in our study, i.e. intimacy 
and sexuality. It appears particularly important to explore this domain among cALL survivors, as 
recent studies have reported that intimacy and sexuality are strongly impacted.61-63 This is even 
more obvious at an age when the child, adolescent or young adult is in the process of building their 
identity and exploring intimate relationships with others.64,65 In addition, childhood leukemia 
cancer survivors have fewer higher education and occupational achievements.66 Future qualitative 
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studies may be particularly relevant for exploring a person’s needs in these domains. Moreover, to 
our knowledge, no study explored unmet needs among other pediatric populations in a similar 
manner. Further studies should explore unmet needs in other oncologic and non-oncologic chronic 
childhood conditions to explore whether these needs can be condition- or age-related. 
The participants of the present study were specifically selected based on health criteria. In this 
group, we found that the following factors related to their condition were associated with unmet 
needs: clinical comorbidities, functional health status and pain. Participants presenting several 
comorbidities expressed moderate/high needs for information and access and continuity of care. 
More specifically, the presence of neurocognitive morbidity was significantly associated with 
information and emotional health and relationship needs. Likewise, bone morbidities were 
associated with the need for access and continuity of care. A systematic review of adult cancer 
survivors found that comorbidities, symptoms and quality of life were associated with higher levels 
of unmet needs.59 In the present study, younger age was also associated with unmet needs. 
Participants younger than 26 years old reported more financial concerns than the older, highlighting 
an issue that may be specific to cALL survivors, as financial concerns are less prevalent in adult 
survivors of hematological cancers.55-58 This is probably the result of higher financial strain on 
pediatric cancer survivors resulting from their younger age and the responsibilities that accompany 
young adulthood. 
We should acknowledge several limitations of this study. First, the limited sample size did not 
allow us to carry out multivariate analyses that would have allowed us to isolate the unique effects 
of the contributing factors. As Figure 1 illustrates, a detailed description of the participants’ clinical 
context quickly yields small cell numbers. Second, 96% of our participants were Caucasians. Thus, 
the results are not generalizable to all ethnic groups. Third, although we based our analysis on a 
recognized questionnaire of unmet needs, our data potentially overlooked some aspects of cALL 
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survivors’ unmet needs (e.g. intimacy-sexuality). To ensure appropriate and targeted care, future 
research should continue exploring cALL survivors’ needs in larger samples, using surveys 
specifically developed for the younger adult population. Researchers should also consider 
conducting further studies in more varied samples.  
In conclusion, in a group of 72 vulnerable cALL survivors, the most frequent unmet needs were 
related to financial concerns and emotional aspects. The levels of unmet needs were related to the 
presence of clinical comorbidity, lower functional status, pain, as well as younger age and higher 
risk status. The results stress the complexity of distinguishing and studying different groups of 
participants based on their clinical profiles, as multi-morbidity is frequent. Future research should 
expand this line of research by improving profiling methods in larger samples and specifying the 
needs surveyed in childhood cancer survivors to better describe the needs of young adult survivors, 
as most tools have been developed for the much older adult populations. 
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 Participants included 
in study Phase II 
(n = 72) 
 Participants included 
in study Phase I (n = 
247) 
p 
 n %  n % 
Demographic characteristics  
Sex 
   Male 














Age (mean in years, SD) 26.79 (5.89) -  21.65 (6.34) - <.001 
Marital status 
   Single 
   Married 
   Common law 
   Divorced 



























   Caucasian 















   Working full-time 
   Working part-time 
   Unpaid work or unemployed 






















Number of children 
   0 
   1 
   2 






















Clinical characteristics  
Time since diagnosis (mean 
in years, SD) 
16.58 (5.96) -  15.54 (5.20) - .180 
DFCI protocol 
   87-01 
   91-01 
   95-01 
   2000-01 
   2005-01 































   Yes 














ALL risk status 
   High risk 
   Standard risk 


















Legend: ALL = acute lymphoblastic leukemia; DFCI = Dana Farber Cancer Institute; SD = standard 
deviation. 
Note: Statistical differences between participants phase I and II were computed with Pearson’s chi-square 
test or Fisher’s exact test for categorical variables and with Student’s T-test for numerical variables. 
  
Comorbidities 
   Metabolism  
       Yes 



















   Bone  
       Yes 
       No 


















   Cardiac  
       Yes 














   Neurocognitive  
       Yes 














Table 2. Levels of unmet needs per domain on the SF-SUNS (n = 72 cALL survivors from the 
PETALE study). 












 n (%) n (%) n (%) n (%) n (%) 
No unmet need (0) 
Low unmet need (0 to 1) 
Low to moderate unmet need (1 to 3) 





















Mean level of unmet need (SD) 0.22 (0.49) 0.44 (0.59) 0.28 (0.58) 0.60 (0.71) 0.45 (0.52) 
Range 0 – 2.67 0 – 3 0 – 3.17 0 – 2.69 0 – 2.3 
Legend: SD = standard deviation. 
 
Figure 1. Co-occurrences of clinically rated comorbidities in adults from PETALE Phase II 






Figure 2. Levels of unmet needs per item on the SF-SUNS (n = 72 cALL survivors from the 
PETALE study). 
 
Items labels’ (Campbell et al., 2014) :  Item #1: Finding information about complementary or alternative 
therapies; item #2: Dealing with fears about cancer spreading; item #3: Dealing with worry about whether 
the treatment has worked; item #4: Worry about earning money; item #5: Having to take a pension or 
disability allowance; item #6: Paying household bills or other payments; item #7: Finding what type of 
financial assistance is available and how to obtain it; item #8: Finding car parking that I can afford at the 
hospital or clinic; item #9: Understanding what is covered by my medical insurance or benefits; item #10: 
Knowing how much time I would need away from work; item #11: Doing work around the house (cooking, 
cleaning, home repairs etc.); item #12: Having access to cancer services close to my home; item #13: Getting 
appointments with specialists quickly enough (oncologist, surgeon etc.); item #14: Getting test results 
quickly enough; item #15: Having access to care from other health specialists (eg dieticians, physiotherapists, 
occupational therapists); item #16: Making sure I had enough time to ask my doctor or nurse questions; item 
#17: Getting the health care team to attend promptly to my physical needs; item #18: Telling others how I 
was feeling emotionally; item #19: Finding someone to talk to who understands and has been through a 
similar experience; item #20: Dealing with people who expect me to be “back to normal” ; item #21: Dealing 
with people accepting that having cancer has changed me as a person; item #22: Dealing with reduced 
support from others when treatment has ended; item #23: Dealing with feeling depressed; item #24: Dealing 
with feeling tired; item #25: Dealing with feeling stressed; item #26: Dealing with feeling lonely; item #27: 
Dealing with not being able to feel ‘normal’; item #28: Trying to stay positive; item #29: Coping with having 





Figure 3. Mean levels of unmet needs according to the number of comorbidities (n = 72 cALL 
survivors from the PETALE study). 
 
Legend: SF-SUNS = The Survivor Unmet Needs Survey short form. 
Note: Among all the participants, 16 participants had no comorbidity, 30 had one among metabolic, bone or 





Appendix Figure 1. Flowchart of participants. 
 















































    	 













































































































































































Appendix Table 1. Mean age at diagnosis according to the presence or absence of late adverse 
effects (n = 72). 
 
Late adverse effects 
Age at diagnosis (mean - SD) 

















Legend: ** = p < .01. Significant results were highlighted in bold.
Appendix Table 2. Mean levels of unmet needs according to morbidity status, and demographic and clinical characteristics (n = 72). 
Domains of unmet need  
(mean – SD) 
Bone   Cardiac   Neurocognitive   Metabolic  
Yes 
(n = 24) 
No 
(n = 48) 
U  Yes 
(n = 8) 
No 
(n = 64) 
U  Yes 
(n = 21) 
No 
(n = 51) 
U  Yes 
(n = 39) 
No 




Access and continuity of care 


















































Domains of unmet need  
(mean – SD) 
Sex  Age a  Marital status (single)  Has children 
Women 
(n = 34) 
Men 
(n = 38) 
U  < 26 
years 
(n = 37) 
> 26 
years 
(n = 35) 
U  Yes 
(n = 38) 
No 
(n = 33) 
U  Yes 
(n = 19) 
No 




Access and continuity of care 


















































Domains of unmet need  
(mean – SD) 
Psychological follow-up 
received 
 Time since diagnosis a  ALL risk status (high)  Radiotherapy received 
Yes 
(n = 18) 
No 
(n = 54) 
U  < 16 
years 
(n = 32) 
> 16 
years 
(n = 40) 
U  Yes 
(n = 52) 
No 
(n = 19) 
U  Yes 
(n = 58) 
No 




Access and continuity of care 

















































Legend: a = groups were created to be as homogeneous as possible; ALL = acute lymphoblastic leukemia; SD = standard deviation; * = p < .05; ** = p < .01. Significant results were highlighted in bold.
Appendix Table 3. Mean levels of unmet needs according to the presence of metabolic 
(n = 15), bone (n = 10) or neurocognitive (n = 5) morbidity alone (comorbidity excluded). 
 
Domains of unmet need  
(mean – SD) 
Late adverse effect 
Metabolic 
(n = 15) 
Bone 
(n = 10) 
Neurocognitive 






Access and continuity of care 

















Legend: SD = standard deviation. 
 
 
Appendix Table 4. Association between unmet needs, pain and functional status. 
 
Measures 
BPI pain severity 
(n = 68) 
BPI pain 
interference 
(n = 68) 
Functional status 
15D 
(n = 66) 
Domains of unmet needs 
   Information 
   Financial concerns 
   Access and continuity of care 
















Mean (SD) 1.71 (1.85) 1.17 (1.78) 0.92 (0.08) 
Scope 0 – 6,5 0 – 7,29 0.68 – 1 
Legend: 15D = instrument of health-related quality of life; BPI = brief pain inventory; SD = standard deviation; * = p < .05; 
** = p < .01. 
 
